Board meeting on October 29, 2026 to consider unaudited results for quarter and half year ended September 30, 2026
Ind-Swift Laboratories has called a Board meeting on Thursday, October 29, 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Thursday, October 29, 2026
- Agenda Period
- quarter and half year ended 30th September, 2026
- Trading Window Closure Intimation Date
- letter dated September 28, 2026
What the Board meeting is for
Ind-Swift Laboratories Ltd. has informed BSE and NSE that a meeting of its Board of Directors is scheduled to be held on Thursday, October 29, 2026.
The stated agenda
- Consider, approve and take on record the Standalone Un-Audited Financial Results of the Company for the quarter and half year ended 30th September, 2026.
- Consider, approve and take on record the Consolidated Un-Audited Financial Results of the Company for the quarter and half year ended 30th September, 2026.
The update describes this as the inter-alia purpose of the meeting.
Why a board meeting notice matters
A listed company must tell the exchanges in advance when its Board will meet to consider financial results. This gives the market prior notice of the date on which the numbers for the period will be approved and taken on record. Investors can note the date, October 29, 2026, as the point at which the results for the quarter and half year ended 30th September, 2026 are scheduled to be approved.
Trading window
The company states in the notice that the information regarding closure of the Trading Window for dealing in the securities of the Company was already provided to the Stock Exchanges where its shares are listed, vide its letter dated September 28, 2026. Separate details of that closure are not part of this notice.
Where to find it
The notice states that this information is also available on the Company's website at www.indswiftgroup.com under the head Investors.
The update is a scheduled Board meeting intimation, signed by Pardeep Verma, VP-Corporate Affairs & Company Secretary.
Also from Ind-Swift Laboratories
Ind-Swift Laboratories Ltd promoter buys 1.58% stake, holding rises to 43.84%
12 Oct 2026
Promoter entity acquires 14,00,000 shares on conversion of fully convertible warrants
12 Oct 2026
Committee approves allotment of 14,00,000 equity shares on conversion of warrants
8 Oct 2026
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.